Results 231 to 240 of about 893,341 (363)

Osteosarcoma metastatic to the thyroid gland: A rare case report. [PDF]

open access: yesTurk J Surg
Soylu S   +4 more
europepmc   +1 more source

Predictive Effect of FT3 Within the Euthyroid Range on HDL‐C in Patients With Type 2 Diabetes: A Cross‐Sectional Analysis of Inpatients in China

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Our research is important for identifying the optimal FT3 range to delay the progression of cardiovascular disease in patients with T2DM. These findings provide valuable insights to guide clinicians in preventing and managing cardiovascular disease in this population.
Jinmei Xu   +3 more
wiley   +1 more source

Comparison of Enzyme‐Linked Immunosorbent Assay and Lateral Flow Assay to Measure Thyroid‐Stimulating Hormone and Free T4 in Human Serum

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
TSH and fT4 measured by EIA and EFL were evaluated by two regression models: Deming and Passing Bablok. The Deming regression for TSH shows that the mean levels obtained by both methods do not present significant differences; however, the Passin‐Bablok regression identifies significant bias between both methods in the range of concentrations studied ...
Rolando Advíncula‐Espino   +2 more
wiley   +1 more source

Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report

open access: yesThoracic Cancer, Volume 13, Issue 23, Page 3408-3411, December 2022., 2022
We present a case treated with “lenvatinib rechallenge” for advanced thymic carcinoma who was previously treated with lenvatinib followed by multiple cytotoxic agents. Shortly after lenvatinib rechallenge, rapid pleural and pericardial effusion reduction was observed. Our case might suggest lenvatinib rechallenge as a treatment option for patients with
Yuto Terashima   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy